Sacubitril/valsartan reduces NT-proBNP, a biomarker predictive of long-term clinical outcomes in heart failure, but does not improve functional capacity compared to individualized background therapy in patients with heart ...
Aug 31, 2020
0
4
A study recently published in the journal Circulation looks at temporal trends in the burden of comorbidities and associated risk of mortality among patients with heart failure (HF) with preserved ejection fraction (HFpEF), ...
Jul 30, 2020
0
4
People with higher levels of a specific inflammatory marker may have a greater risk of developing a form of heart failure, according to new research that could help predict who might develop the disease.
Jul 28, 2020
0
1
A receptor that plays an essential role in safely clearing chronic unresolved cardiac inflammation may offer new targets for treating an increasing type of heart failure associated with age-related obesity, suggests a preclinical ...
Jun 22, 2020
0
30
(HealthDay)—Many patients with heart failure might live years longer if they were on a combination of newer medications, a study suggests.
May 27, 2020
0
5
(HealthDay)—Greater genetic predisposition for multiple sclerosis (MS) is associated with altered brain white matter development at an early age, according to a study published online March 12 in the Annals of Neurology.
Apr 6, 2020
0
2
While there is an association between liver fibrosis and heart failure, the mechanisms for this association are currently unclear but may be of particular importance for people living with human immunodeficiency virus (HIV) ...
Mar 6, 2020
0
1
Illicit performance-enhancing steroids can cause the heart to thicken and reduce its ability to function, according to research presented today at ESC Congress 2019 together with the World Congress of Cardiology.
Sep 1, 2019
0
3
The number of patients with heart failure with preserved ejection fraction is on the rise, and the search is on for a therapy that can improve health outcomes in this group of patients for whom no approved therapies are available. ...
Sep 1, 2019
0
1
A drug used to treat attention-deficit/hyperactivity disorder (ADHD) appears to affect the development of the brain's signal-carrying white matter in children with the disorder, according to a study published in the journal ...
Aug 13, 2019
0
16
